Latest biopharmaceutical Stories
SANTA ROSA, Calif., May 5, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics
Conference Call and Webcast to Follow THE WOODLANDS, Texas, May 5, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals,
Spin-off Would Allow Cytocom to Operate as a Separate Biotechnology Company Focused on Development of LDN and MENK Immunotherapy Products ORLANDO, Fla., May 1, 2014 /PRNewswire/ -- TNI BioTech,
ATLANTA, April 30, 2014 /PRNewswire/ -- Today, the U.S.
Gallus BioPharmaceuticals, a premier pure-play biologics contract development and manufacturing organization and Omni Bio Pharmaceutical, a biopharmaceutical company focused on the commercialization
MONROVIA, Calif., April 29, 2014 /PRNewswire/ -- Xencor, Inc.
ATLANTA and MELBOURNE, Australia, April 28, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
AUSTIN, Texas, April 15, 2014 /PRNewswire/ -- XBiotech announced today that Robert Lindsey has joined the Company as Senior Vice President Corporate Development & General Counsel. Mr.
Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database.
MONROVIA, Calif., April 10, 2014 /PRNewswire/ -- Xencor, Inc.
- To swell, as grain or wood with water.